Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3

Journal of Clinical Investigation

Volumn 98, Issue 11, 1996, Pages 2612-2615

  Harrela, M ^a   Koistinen, H ^a   Kaprio, J ^b   Lehtovirta, M ^a   Tuomilehto, J ^c   Eriksson, J ^c   Toivanen, L ^c   Koskenvuo, M ^d   Leinonen, P ^a,b   Koistinen, R ^a   Seppala M ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^d NONE

Author keywords

dizygotic; genetic regulation; insulin like growth factor; monozygotic; twins

Indexed keywords

SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN 1; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C;

ADULT; AGED; ARTICLE; CELL GROWTH; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; GENE CONTROL; GENETIC VARIABILITY; HEREDITY; HUMAN; MAJOR CLINICAL STUDY; MONOZYGOTIC TWINS; PRIORITY JOURNAL;

EID: 0029835895     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI119081     Document Type: Article

References (31)

1. Daughaday, W.H., and P. Rotwein. 1989. Insulin-like growth factors I and II, peptide, messenger ribonucleic acid and gene structures, serum and tissue concentrations. Endocr. Rev. 10:68-91.
2. Baxter, R.C., and J.L. Martin. 1989. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog. Growth Factor Res. 1: 49-68.
3. Shimasaki, S., and N. Ling. 1991. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog. Growth Factor Res. 3:243-266.
4. Hintz, R.L., F. Liu, R.G. Rosenfeld, and S.F. Kemp. 1981. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J. Clin. Endocrinol. Metab. 53:100-104.
5. Suikkari, A.-M., V.A. Koivisto, E.-M. Rutanen, H. Yki-Järvinen, S.-L. Karonen, and M. Seppälä. 1988. Insulin regulates the serum levels of low molecular weight insulin-like growth factor- binding protein. J. Clin. Endocrinol. Metab. 66:266-272.
6. Angervo, M., P. Leinonen, R. Koistinen, M. Julkunen, and M. Seppälä. 1993. Triiodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells. J. Mol. Endocrinol. 10:7-13.
7. Angervo, M., J. Toivonen, P. Leinonen, M. Välimäki, and M. Seppälä. 1993. Thyroxine withdrawal decreases insulin-like growth factor binding protein-1 levels in thyroidectomized patients. J. Clin. Endocrinol. Metab. 76:1199-1201.
8. Ullrich, A., C.H. Bergman, T.J. Dull, A. Gray, and J.M. Lee. 1984. Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe. EMBO (Eur. Mol. Biol. Organ.) J. 3:361.
9. de Pagter-Holthuisen, P., F.M.A. van Shaik, G.H. Verduijn, G.J.B. van Ommen, B.N. Bouma, M. Jansen, and J.S. Sussenbach. 1986. Organisation of the human genes for insulin-like growth factors I and II. FEBS Lett. 195:179.
10. Alitalo, T., K. Kontula, R. Koistinen, K. Aalto-Setälä, M. Julkunen, O. Jänne, M. Seppälä, and A. de la Chapelle. 1989. The gene encoding human low molecular weight insulin-like growth factor binding protein (IGFBP25): Regional localisation to 7p12-p13 and description of DNA polymorphism. Hum. Genet. 83:335-338.
11. Ehrenborg, E., C. Larsson, I. Stern, M. Janson, and D.R. Powell. 1992. Contiguous localisation of the genes encoding human insulin-like growth factor binding proteins 1 (IGFBP-1) and 3 (IGFBP-3) on chromosome 7. Genomics. 12:497-502.
12. Kao, P.C., A.P. Matheny, Jr., and C.A. Lang. 1994. Insulin-like growth factor-I comparisons in healthy twin children. J. Clin. Endocrinol. Metab. 78: 310-312.
13. Kaprio, J., S. Sarna, M. Koskenvuo, and I. Rantasalo. 1978. The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures and research program. Prag. Clin. Biol. Res. 24 Pt B:179-184.
14. Sarna, S., J. Kaprio, P. Sistonen, and M. Koskenvuo. 1978. Diagnosis of twin zygosity by mailed questionnaire. Hum. Hered. 28:241-254.
15. Koistinen, H., M. Seppälä, and R. Koistinen. 1994. Different forms of insulin-like growth factor binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin. Chem. 4:531-536.
16. Koistinen, R., O. Itkonen, P. Selenius, and M. Seppälä. 1990. Insulin-like growth factor binding protein-1 inhibits binding of IGF-1 on the fetal skin fibroblasts but stimulates their DNA synthesis. Biochem. Biophys. Res. Commun. 173:408-415.
17. Koistinen, H., R. Koistinen, L. Selenius, O. Ylikorkala, and M. Seppälä. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. 1996. J. Appl. Physiol. 80(3). 760-764.
18. Williams, C.J., J.C. Christian, and J.A. Norton, Jr. 1992. TWINAN 90-a Fortran program for conducting ANOVA-based and likelihood-based analyses of twin data. Comput. Methods Programs Biomed. 38:167-176.
19. Neale, M.C., and L.R. Cardon. 1992. Methodology for genetic studies of twins and families. Kluwer Academic Publishers, Dordrechr, The Netherlands.
20. Hall, K., and V.R. Sara. 1984. Somatomedin levels in childhood, adolescence and adult life. J. Clin. Endocrinol. Metab. 13:91-112.
21. Blum, W.F., and M.B. Ranke. 1991. Plasma IGFBP-3 levels as clinical indicators. In Modern Concepts of Insulin-like Growth Factors. E.M. Spencer, editor. Elsevier Science, New York. 381-393.
22. Blum, W.F., K. Albertssons-Wikland, S. Rosberg, and M.B. Ranke. 1993. Serum levels of insulin-like growth factor-I and IGF binding protein-3 reflect spontaneous growth hormone secretion. J. Clin. Endocrinol. Metab. 76: 1610-1616.
23. Jahanfar, S., J. A. Eden, P. Warren, M. Seppälä, and T.V. Nguyen. 1995. A twin study of polycystic ovary syndrome. Fertil. Steril. 63:478-486.
24. Cohen, K.L., and S. P. Nissley. 1976. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta endocrinol. 83: 243-258.
25. Giudice, L.C., E.M. Farrell, H. Pham, G. Lamson, and R.G. Rosenfeld. 1990. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J. Clin Endocrinol. Metab. 71:806-816.
26. Davenport, M.L., D.R. Clemmons, M.V. Miles, C. Camacho-Hubner, A.J. D'Ercole, and L.E. Underwood. 1990. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology. 127:1278-1286.
27. Davies, S.C., J.A. Wass, R.J. Ross, A.M. Cotterill, C.R. Buchanan, V.J. Coulson, and J.M. Holly. 1991. The induction of specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J. Endocrinol. 130:469-473.
28. Davenport, M., W. Isley, J. Pucilowskaja, L. Pemberton, B. Lyman, L. Underwood, and D. Clemmons, 1992. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J. Clin. Endocrinol. Metab. 75:590-595.
29. Bereket, A., C.H. Lang, S.L. Blethen, J. Fan, R.A. Frost, and T.A. Wilson. 1995. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J. Clin. Endocrinol. Metab. 80:2282-2288.
30. Giudice, L.C. 1995. IGF binding protein-3 protease regulation: How sweet it is! J. Clin. Endocrinol. Metab. 80: 2279-2281.
31. Vihervuori, E., M. Virtanen, H. Koistinen, R. Koistinen, M. Seppälä, and M.A. Siimes. 1996. Hemoglobin level is linked to growth hormone-dependent proteins in short children. Blood. 87:2075-2081.